Literature DB >> 898535

Studies on the pathogenesis of cancer hypercalcemia.

W P Laird Myers, R Bockman.   

Abstract

The pathogenesis of hypercalcemia in cancer continues to challenge the clinical investigator. Some aspects of this subject have been reviewed, notably with respect to the possible roles of prostaglandins and osteoclast activating factor, with particular reference to breast cancer. There is considerable evidence that the former humoral factor is operative and beginning evidence that the latter may be also. The hope in this continued work is that with better understanding of the mechanisms of hypercalcemia and bone loclization of tumors we will be in a far better position to control and interdict this localization.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 898535      PMCID: PMC2441416     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  25 in total

1.  Hypercalcemia in neoplastic disease.

Authors:  W P L MYERS
Journal:  Cancer       Date:  1956 Nov-Dec       Impact factor: 6.860

2.  The effect of hypervitaminosis A on embryonic limb bones cultivated in vitro.

Authors:  H B FELL; E MELLANBY
Journal:  J Physiol       Date:  1952-03       Impact factor: 5.182

Review 3.  Calcium homeostasis and the patogenesis and management of hypercalcemic disorders.

Authors:  A B Schneider; L M Sherwood
Journal:  Metabolism       Date:  1974-10       Impact factor: 8.694

4.  Hyperparathyroidism associated with malignant tumors of nonparathyroid origin.

Authors:  G S Omenn; S I Roth; W H Baker
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

5.  Prostaglandins: stimulation of bone resorption in tissue culture.

Authors:  D C Klein; L G Raisz
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

6.  Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease.

Authors:  R C Benson; B L Riggs; B M Pickard; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

7.  Bone-resorbing activity in supernatants from lymphoid cell lines.

Authors:  G R Mundy; R A Luben; L G Raisz; J J Oppenheim; D N Buell
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

8.  Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.

Authors:  T J Powles; M Dowsett; G C Easty; D M Easty; A M Neville
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

9.  Breast cancer, prostaglandins, and bone metastases.

Authors:  A Bennett; A M McDonald; J S Simpson; I F Stamford
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

10.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.